These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 25102221)

  • 1. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.
    Chmiel JF; Aksamit TR; Chotirmall SH; Dasenbrook EC; Elborn JS; LiPuma JJ; Ranganathan SC; Waters VJ; Ratjen FA
    Ann Am Thorac Soc; 2014 Sep; 11(7):1120-9. PubMed ID: 25102221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.
    Conway SP; Brownlee KG; Denton M; Peckham DG
    Am J Respir Med; 2003; 2(4):321-32. PubMed ID: 14719998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on antibiotics for infection control in cystic fibrosis.
    Kirkby S; Novak K; McCoy K
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):967-80. PubMed ID: 19803706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Microbiological diagnosis of bronchopulmonary colonization-infection in cystic fibrosis].
    Oliver A; Alarcón T; Caballero E; Cantón R
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):89-104. PubMed ID: 19232782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis.
    Murray TS; Stanley G; Koff JL
    Infect Dis Clin North Am; 2024 Mar; 38(1):149-162. PubMed ID: 38280761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cystic fibrosis lung microbiome.
    Surette MG
    Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and management of pulmonary infections in cystic fibrosis.
    Gibson RL; Burns JL; Ramsey BW
    Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Virulence Potential of Livestock-Associated Methicillin-Resistant
    Treffon J; Fotiadis SA; van Alen S; Becker K; Kahl BC
    Toxins (Basel); 2020 May; 12(6):. PubMed ID: 32486247
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bacterial isolates from respiratory samples of pediatric patients with cystic fibrosis and their distribution by ages].
    Busquets NP; Baroni MR; Ochoteco MC; Zurbriggen ML; Virgolini S; Meneghetti FG
    Rev Argent Microbiol; 2013; 45(1):44-9. PubMed ID: 23560788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.
    Ahmed MI; Mukherjee S
    Cochrane Database Syst Rev; 2016 Mar; 3():CD011581. PubMed ID: 27003247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing Incidence of Multidrug Resistance Among Cystic Fibrosis Respiratory Bacterial Isolates.
    Rutter WC; Burgess DR; Burgess DS
    Microb Drug Resist; 2017 Jan; 23(1):51-55. PubMed ID: 27326758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.
    Fusco NM; Toussaint KA; Prescott WA
    Ann Pharmacother; 2015 Apr; 49(4):458-68. PubMed ID: 25583881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.
    Ahmed MI; Mukherjee S
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011581. PubMed ID: 30052271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis lung microbiome: opportunities to reconsider management of airway infection.
    Caverly LJ; Zhao J; LiPuma JJ
    Pediatr Pulmonol; 2015 Oct; 50 Suppl 40():S31-8. PubMed ID: 26335953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial Interactions in the Cystic Fibrosis Airway.
    Granchelli AM; Adler FR; Keogh RH; Kartsonaki C; Cox DR; Liou TG
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29769279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
    Aanæs K
    J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues.
    Waters V; Ratjen F
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):807-19. PubMed ID: 17140357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing Pulmonary Infection in Adults With Cystic Fibrosis: Adult Cystic Fibrosis Series.
    Green HD; Jones AM
    Chest; 2022 Jul; 162(1):66-75. PubMed ID: 35167860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis.
    Murray TS; Stanley G; Koff JL
    Clin Chest Med; 2022 Dec; 43(4):667-676. PubMed ID: 36344073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.